Primary analysis of phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma who progressed on or were intolerant to hedgehog inhibitors Journal Article


Authors: Lewis, K. D.; Perris, K.; Sekulic, A.; Stratigos, A.; Dücker, P.; Eroglu, Z.; Chang, A. L. S.; Migden, M. R.; Yoo, S. Y.; Mohan, K.; Coates, E.; Okoye, E.; Baurain, J. F.; Bechter, O.; Hauschild, A.; Butler, M. O.; Hernandez-Aya, L.; Licitra, L.; Neves, R. I.; Ruiz, E. S.; Seebach, F.; Lowy, I.; Goncalves, P.; Fury, M. G.
Article Title: Primary analysis of phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma who progressed on or were intolerant to hedgehog inhibitors
Journal Title: Journal Der Deutschen Dermatologischen Gesellschaft
Volume: 20
ISSN: 1610-0379
Publisher: Wiley Blackwell  
Date Published: 2022-01-01
Start Page: 105
End Page: 106
Language: English
ACCESSION: WOS:000851869200181
PROVIDER: wos
Notes: Meeting Abstract -- 3 -- SI -- Source: Wos